Our results are supported by several studies showing that mild endogenous SPK2 activation is one of the protective mechanisms in both cerebral ischemia and myocardial ischemia.66, 67 SPK2-mediated mechanism is involved in the protective effects of allicin against cerebral ischemia both in vivo and in vitro. The gene discussed is SPHK2; the disease is myocardial ischemia.